Growth Stock Analytics-High EPS and Relative Strength Stock Market Trading System Growth Stock Analytics-High EPS and Relative Strength Stock Market Trading System
Growth Stock Investing and Trading for Stock Market Investors - Since 1996 | MyStockScreen.com | Home | Join Now | Member Login | Refer a Friend | Contact Us
Your Best Source For Top Stock Picks, Stock Rankings, Stock Screening, Swing Trading, Market Direction and More...
HI-EPSRS
Screener
My Watch
List
Market
Direction
Industry
Map
My
Account
Help Logout
Symbol:
Enter Symbols Separated By Spaces.
Download All Symbols To Text/CSV

Top Picks Watch List
Dist.Days: SPY:4 DOW:4 QQQ:2

GSA Live Portfolio:
FNSR PRO
2022-11-08: We have a signal to move out of CASH and into FBSOX....Read more

HI-EPSRS Database Search Results   

Search Results      Stocks 1 through 1 of 1 shown        Download Search Results Symbols To Text/CSV

OraSure Technologies Inc (OSUR)
Vital Signs
GSA
Rank

Stock Ranking
Earnings
Consistency

EPS Consistency Ranking

0.5/1.0
Sales
Consistency

Sales Consistency Ranking

0.7/1.0
Looks Like
A Winner?

Looks Like A Winner Ranking

1/10
Entry Risk
Above Support

Price Above Stop Loss Ranking

20%
Group
Action

Group Action Ranking

24
"Must Have"/Timing Factors
GSA
52.54
Acc Dist
0.74
Disc
223.68%
Avg Vol
1,031,100
Liquidity
2.33%
Below High
28.81%
Group Action
24
3-Month Trends of Key Indicators:
Fundamental/Technical Factors
Qrtly EPS
-18%  29%
EPS Growth
131%
Sls Growth
10%
Proj Growth
12.5%
Anal. Rank
4.00
Shares
60.7M
Instit
96%
3-Month Trends of Key Indicators:
Looks Like a Winner?
OSUR looks better than most Top Picks Winners* in 1 out of 10 key factors.
Accum/Dist: 0.74 (median winner: 1.53)
Above 40wkMA: -2% (median winner: 35%)
Instit. Ownership: 96% (median winner: 63%)
Liquidity: 2.33% (median winner: 1.18%)
Group Action: 24 (median winner: 20)
GSA Rank: 52.54 (winner: 75.66)
Sales Growth: 10% (median winner: 28%)
Below 52wk High: 28.81% (winner: 3.30%)
Relative Strength: 84 (winner: 96)
Avg Qrtly EPS: 5% (median winner: 68%)
Industry Group: 24. Medical Instruments & Supplies

Instit.   Insiders   Yahoo   Zacks   MSN   Google Finance   Daily Charts   Web Site

Orasure Technologies Inc: OraSure Technologies is a medical diagnostics company with a focus on point-of-care testing with products that use oral fluid samples and return accurate results in a matter of minutes. By streamlining the sample collection process and improving assay sensitivity, our products significantly improve the way diagnostic testing is conducted. The Company also markets a patented portable cryosurgical system for use by medical professionals in point-of-care settings.

  • OraSure Technologies, Inc.: Fading performance but may be making a comeback? Wed, 22 Nov 2017 16:58:59 +0000
    Categories: Yahoo FinanceOraSure Technologies, Inc. relative valuation is NEUTRAL and it has a fundamental analysis score of 84. Our analysis is based on comparing OraSure Technologies, Inc. with the following peers – Trinity Biotech Plc Sponsored ADR Class A, Cooper Companies, Inc., Riot Blockchain Inc, Quidel Corporation, Response Genetics, Inc., Quest Diagnostics Incorporated, ERBA Diagnostics, Inc., Chembio ... Read more (Read more...)
  • Today’s Research Reports on Stocks to Watch: Medtronic and Orasure Technologies Wed, 22 Nov 2017 13:10:00 +0000
    NEW YORK, NY / ACCESSWIRE / November 22, 2017 / Shares of Medtronic closed up nearly 5% after beating in both the top and bottom line in its second quarter earnings report. Shares of OraSure technologies ...
  • Why OraSure Technologies, Inc. Zoomed Higher Today Tue, 21 Nov 2017 21:23:00 +0000
    A large sale to a single customer has investors excited about the diagnostic company's prospects.
  • Stocks To Watch: Orasure Technologies Sees Relative Strength Rating Jump To 83 Mon, 06 Nov 2017 08:00:00 +0000
    Orasure Technologies shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 70 to 83.
  • Is This Why OraSure Technologies, Inc. Is Tanking Today? Thu, 02 Nov 2017 18:13:00 +0000
    Shares plunged even though the company reported upbeat results. What gives?
  • ETFs with exposure to OraSure Technologies, Inc. : October 20, 2017 Fri, 20 Oct 2017 14:21:35 +0000
    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to OraSure Technologies, Inc. Here are 5 ETFs with the largest exposure to OSUR-US. Comparing the performance and risk of OraSure Technologies, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
  • OraSure Technologies, Inc. – Value Analysis (NASDAQ:OSUR) : October 18, 2017 Wed, 18 Oct 2017 14:16:31 +0000
    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives OraSure Technologies, Inc. a score of 84. Our analysis is based on comparing OraSure Technologies, Inc. with the following peers – Trinity Biotech Plc Sponsored ADR Class A, Cooper Companies, Inc., BiOptix, Inc., Quidel Corporation, Response Genetics, Inc., Quest Diagnostics Incorporated, ERBA Diagnostics, Inc., Chembio Diagnostics, Inc., ... Read more (Read more...)
  • OraSure Technologies, Inc. breached its 50 day moving average in a Bearish Manner : OSUR-US : October 17, 2017 Tue, 17 Oct 2017 12:16:00 +0000
    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for OraSure Technologies, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more (Read more...)
  • OraSure Technologies Earnings Conference Call Invitation Wed, 11 Oct 2017 10:00:00 +0000
    BETHLEHEM, Pa., Oct. 11, 2017-- OraSure Technologies, Inc. has scheduled its regular earnings conference call covering 2017 third quarter financial results, 2017 fourth quarter financial guidance and certain ...
  • Edwards Lifesciences Pipeline Impressive, Currency Woes Stay Mon, 02 Oct 2017 14:02:02 +0000
    Edwards Lifesciences (EW) rides high on product launches as well as strength in the global Transcatheter Aortic Valve Replacement market.

Stock Research
Weekly-1Yr Daily-3Mo Daily-6Mo Daily-1Yr
Daily-6Mo w/2-ATR Stops 3-ATR 4-ATR
Daily-1 Yr (opens in new window)
(Larger Charts. ATR=Average True Range)

Stock Research
Rel Str Acc/Dist Grp Action Instit Disc%

Quarterly EPS GrowthQuarterly Sales Growth
OSUR EPS/Sales Growth OSUR vs. Peers



*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Copyright © 1996-2024 Growth Stock Analytics, LLC. All rights reserved.  Site Map | Privacy Policy | Contact Us